South Africa

FuturePharma will support the development, scale up and production of pharmaceutical technologies, helping to address a persistent challenge in the industry: translating scientific discoveries into products that can be manufactured commercially.

The programme, introduced as a long-term pilot, will test whether financial incentives can encourage people to take practical steps to improve their health.

The new APU features natural lighting, well ventilated wards and two secure courtyards designed to create calmer surroundings for patients.

The partnership, developed through sustained engagement led by UNAIDS, is being advanced this week through a SADC-China strategic exchange taking place from 31 August to 4 September 2026 in Johannesburg, Durban and Cape Town.

The agreement covers 129 countries, including all African nations, and gives Aspen rights across both public and private healthcare sectors.

The replenishment will restore supplies at facilities in Tshwane, Johannesburg and Sedibeng that experienced temporary shortages after demand exceeded initial projections following the programme’s rollout in June 2026.

Arya Pharma is implementing the Class II Type A recall in consultation with Sahpra and in accordance with the Medicines and Related Substances Act 101 of 1965, as amended.

The U.S. National Cancer Institute estimates that more than 500 rare cancers exist, many of which receive limited public attention despite their significant impact on patients and families.

Named after King Nyabela of the Ndzundza-Ndebele people, the 220-bed district hospital will provide essential healthcare services to more than 240,000 residents of the Steve Tshwete Local Municipality.